Kidney Neoplasms: all 973 studies
Page 8 of 10. Open to participants first (214), then studies with results posted, then the rest; newest registration first within each.
- The Use of Self Retaining Sutures in Open and Laparoscopic Partial NephrectomyTerminatedNCT01413607Phase 4
- Rotating Pazopanib and Everolimus to Avoid ResistanceCompletedNCT01408004Phase 2
- Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation StudyWithdrawnNCT01401777
- Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney CancerWithdrawnNCT01355562Phase 2
- Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaCompletedNCT01339975
- Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney CancerTerminatedNCT01336231
- Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms TumorCompletedNCT01314391
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell CarcinomaTerminatedNCT01264341Phase 2
- Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)Status unknownNCT01230697
- Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) ScrambleActive, not recruitingNCT01224288Phase 3
- A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue BiopsyCompletedNCT01218854Phase 1
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2
- Hepatic and Renal Thermography Using Magnetic Resonance ImagingTerminatedNCT01197820Not applicable
- Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerCompletedNCT01191892Phase 2
- CT Versus CEUS Findings of Complex Cystic Renal LesionsCompletedNCT01159717
- Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)CompletedNCT01122615Phase 1
- Biomarkers in Tissue Samples From Patients With High-Risk Wilms TumorCompletedNCT01118078
- Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerStatus unknownNCT01118039Phase 2
- Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney CancerStatus unknownNCT01105364Not applicable
- Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared ImagingWithdrawnNCT01104389Not applicable
- Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney CancerStatus unknownNCT01099423Phase 3
- Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT01090466Phase 1/2
- Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)CompletedNCT01089088Phase 2
- Detection of Renal Malignancy of Complicated Renal CystsCompletedNCT01087060
- A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal CancersTerminatedNCT01086696Early Phase 1
- Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 TherapyTerminatedNCT01068470
- Sunitinib in Metastatic Renal CancerCompletedNCT01034878Phase 2
- Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to TreatmentCompletedNCT01031875Phase 2
- Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney CancerCompletedNCT01024205Phase 2
- Percutaneous Renal Tumor Cryoablation Followed by BiopsyCompletedNCT01012427Phase 1
- Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung CancersCompletedNCT01005797Phase 1
- Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms TumorsCompletedNCT01004783
- Novel Prognostic Markers in Renal CancerCompletedNCT01002937
- A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family MembersStatus unknownNCT00994188Not applicable
- A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third PartiesStatus unknownNCT00980317Not applicable
- Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus SunitinibCompletedNCT00979966Phase 2
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedNCT00967577Phase 1
- Sunitinib Malate in Treating Patients With Kidney CancerCompletedNCT00943839Not applicable
- Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell CancerTerminatedNCT00942058
- Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 ReceptorTerminatedNCT00923390Phase 1
- Cryoablation Versus Radiofrequency Ablation for Small Renal MassesWithdrawnNCT00922948Phase 2
- Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney CancerWithdrawnNCT00908739
- DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCECompletedNCT00900536
- Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsCompletedNCT00900276
- SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney CancerCompletedNCT00900042
- Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney CancerTerminatedNCT00899860
- Study of Kidney Tumors in Younger PatientsCompletedNCT00898365
- Gene Expression Profiles to Categorize Wilms TumorsCompletedNCT00897637
- A Pilot Study of Renal Hypothermia During Partial NephrectomyCompletedNCT00888641Phase 1
- MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney CancerStatus unknownNCT00873236Phase 2
- Study In Patients With Kidney Cancer Treated With SutentCompletedNCT00873210
- Study of Cryotherapy for Renal TumorsWithdrawnNCT00858975Not applicable
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell CancerTerminatedNCT00816686Phase 1
- Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00814021Phase 2
- CyberKnife for Unresectable Renal TumorsCompletedNCT00807339Not applicable
- Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney CancerCompletedNCT00806650
- Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerCompletedNCT00792025Phase 2
- Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWithdrawnNCT00769990Phase 1/2
- Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00757614
- Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By SurgeryTerminatedNCT00747305Phase 1
- Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney CancerCompletedNCT00743236Not applicable
- Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney CancerStatus unknownNCT00717587Phase 2
- Evaluating Renal Masses Using Ultrasound Intravenous Microbubble ContrastCompletedNCT00671411Phase 1
- Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaCompletedNCT00659568Phase 1
- Follow-Up Study of Kidney Cancer PatientsCompletedNCT00656955
- Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.CompletedNCT00656734Phase 1
- Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00626509Phase 2
- Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid TumorsWithdrawnNCT00624962Not applicable
- MT2004-30: Tomotherapy for Solid TumorsTerminatedNCT00623077Phase 1
- Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerCompletedNCT00623064Phase 1
- Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsCompletedNCT00622674Phase 1
- Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1
- Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaCompletedNCT00617799
- A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)CompletedNCT00600496Phase 1
- Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based RegimensCompletedNCT00591188Phase 2
- Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung MetastasesCompletedNCT00588913Phase 1/2
- Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic TumorsCompletedNCT00588276Phase 1
- Spectroscopy With Surface Coils and DecouplingCompletedNCT00581815Phase 1
- Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
- Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell CancerCompletedNCT00541008Phase 2
- Phase 1 Study of OSI-930 in Cancer PatientsCompletedNCT00513851Phase 1
- Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal TumorsStatus unknownNCT00507884
- Biobehavioral Effects of Emotional Expression in CancerCompletedNCT00505310Not applicable
- Ph II Study of Perifosine for Patients With Carcinoma of the KidneyCompletedNCT00498966Phase 2
- Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerTerminatedNCT00492440Phase 1
- Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney CancerCompletedNCT00492258Phase 3
- Evaluation of Diagnostic Value of Molecular Markers in Renal CancerTerminatedNCT00491621Not applicable
- Talabostat in Treating Patients With Metastatic Kidney CancerWithdrawnNCT00489710Phase 2
- OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
- Stereotactic Radiation Therapy in Treating Patients With Kidney TumorsWithdrawnNCT00445757Phase 1
- A Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaCompletedNCT00422344Phase 1
- A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00421512Phase 1
- Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic MelanomaCompletedNCT00418496Phase 1
- Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney CancerCompletedNCT00416871Phase 3
- Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney CancerCompletedNCT00416429Phase 3
- Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerCompletedNCT00405366Early Phase 1
- Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney CancerCompletedNCT00401128Phase 2
- Perifosine + Sunitinib Malate for Patients With Advanced CancersCompletedNCT00399152Phase 1
- Phase I Study of Perifosine + Sorafenib for Patients With Advanced CancersCompletedNCT00398814Phase 1